Sort   by:  
 Page size 
UnknownConvergent clonal selection of donor- and recipient-derived CMV-specific T cells in hematopoietic stem cell transplant patients.
Not available
S-EPMC8833188 | biostudies-literature
UnknownDonor-Derived CD4+ T Cells and Human Herpesvirus 6B Detection After Allogeneic Hematopoietic Cell Transplantation.
Not available
S-EPMC7904283 | biostudies-literature
UnknownNew Insights Into Factors Shaping CMV-Specific T-Cell Polyfunctionality After Hematopoietic Cell Transplantation.
Not available
S-EPMC12766359 | biostudies-literature
UnknownCytomegalovirus-specific T-cell reconstitution following letermovir prophylaxis after hematopoietic cell transplantation.
Not available
S-EPMC8493975 | biostudies-literature
UnknownGenetic and environmental imprints on T cell receptor repertoires as predictors of graft-versus-host disease.
Not available
S-EPMC12767534 | biostudies-literature
UnknownAntibodies against vaccine-preventable infections after CAR-T cell therapy for B cell malignancies.
Not available
S-EPMC8262349 | biostudies-literature
UnknownDurable preservation of antiviral antibodies after CD19-directed chimeric antigen receptor T-cell immunotherapy.
Not available
S-EPMC6880890 | biostudies-literature
UnknownPathogen-Specific Humoral Immunity and Infections in B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy Recipients with Multiple Myeloma.
Not available
S-EPMC9197988 | biostudies-literature
UnknownCytomegalovirus immunity in high-risk liver transplant recipients following preemptive antiviral therapy versus prophylaxis.
Not available
S-EPMC11457861 | biostudies-literature
UnknownELISPOT as a predictor of clinically significant cytomegalovirus infection after hematopoietic cell transplantation in letermovir recipients.
Not available
S-EPMC12818887 | biostudies-literature
Sort   by:  
 Page size